Showing 1 - 5 results of 5 for search 'Vered Abitbol', query time: 0.25s
Refine Results
-
1
Navigating adalimumab biosimilars: an expert opinion by Vered Abitbol, Salim Benkhalifa, Caroline Habauzit, Hubert Marotte
Published 2023-10-01Article -
2
Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cells. by Emily Loison, Béatrice Poirier-Beaudouin, Valérie Seffer, Audrey Paoletti, Vered Abitbol, Eric Tartour, Odile Launay, Marie-Lise Gougeon
Published 2014-01-01
Article -
3
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study by Aurelien Amiot, Anne Bourrier, Jean-Marc Gornet, Olivier Dewit, Stephane Nancey, Romain Altwegg, Vered Abitbol, David Laharie, Catherine Reenaers, Charlotte Gagnière, Anthony Buisson, Maria Nachury, Stephanie Viennot, Lucine Vuitton, Carmen Stefanescu, Philippe Marteau, Guillaume Bouguen, Philippe Seksik
Published 2023-03-01
Article -
4
Impact of a dedicated multidisciplinary meeting on the management of superficial cancers of the digestive tract by Solène Dermine, Maximilien Barret, Caroline Prieux, Sophie Ribière, Sarah Leblanc, Marion Dhooge, Catherine Brezault, Vered Abitbol, Benoit Terris, Frédéric Beuvon, Alexandre Rouquette, Bertrand Dousset, Sébastien Gaujoux, Philippe Soyer, Anthony Dohan, Jean-Emmanuel Bibault, Romain Coriat, Frédéric Prat, Stanislas Chaussade
Published 2018-12-01
Article -
5
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID by Bénédicte Caron, Philippe Seksik, Anthony Buisson, Pauline Wils, Guillaume Savoye, Carmen Stefanescu, David Laharie, Lucas Guillo, Vered Abitbol, Joelle Bonnet, Romain Altwegg, Lucine Vuitton, Driffa Moussata, Arnaud Bourreille, Amélie Biron, Cyrielle Gilletta, Mathurin Fumery, Stephane Nahon, Stephane Nancey, Houda Camara, Laurent Peyrin-Biroulet
Published 2024-08-01
Article